Trans-2-enoyl-coenzyme A reductase (reduced nicotinamide adenine dinucleotide phosphate)
RxNorm 320060
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 320060 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Trans-2-enoyl-coenzyme A reductase (reduced nicotinamide adenine dinucleotide phosphate).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
Trans-2-enoyl-CoA reductase (NADPH)
(Atom ID: 1489867)
SY
Synonym (SY):
Trans-2-enoyl-coenzyme A reductase (reduced nicotinamide adenine dinucleotide phosphate)
(Atom ID: 5940437)
FN